We remain one of only a few companies worldwide that has the capability to produce high affinity, humanised anti-glycan antibodies and continue to evaluate options and potential agreements for the Company's GlyMab® antibodies in order to provide further third-party validation, develop the business and generate revenues.”
Any company can offer any amount to buy scancell, and if they make a formal offer then it will be put to a shareholder vote, LD may say it’s too low but she can’t stop it.